158 related articles for article (PubMed ID: 19787618)
41. Intravitreal pegaptanib sodium for Irvine-Gass syndrome.
Querques G; Iaculli C; Delle Noci N
Eur J Ophthalmol; 2008; 18(1):138-41. PubMed ID: 18203101
[TBL] [Abstract][Full Text] [Related]
42. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration.
Singh RP; Sears JE
Am J Ophthalmol; 2006 Jul; 142(1):160-2. PubMed ID: 16815269
[TBL] [Abstract][Full Text] [Related]
43. Intravitreal ranibizumab for pigment epithelium detachment with subfoveal occult choroidal neovascularization: a prospective 24-month case series.
Parodi MB; Iacono P; Papayannis A; Kontadakis SD; Cascavilla M; Pierro L; Gagliardi M; Bandello F
Am J Ophthalmol; 2013 Jan; 155(1):103-108.e2. PubMed ID: 23022164
[TBL] [Abstract][Full Text] [Related]
44. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration.
Spaide RF
Am J Ophthalmol; 2009 Apr; 147(4):644-52. PubMed ID: 19152869
[TBL] [Abstract][Full Text] [Related]
45. MORPHOLOGY SCORE AS A MARKER OF RETINAL FUNCTION IN DRUSENOID PIGMENT EPITHELIAL DETACHMENT.
Clemens CR; Alten F; Heiduschka P; Eter N
Retina; 2015 Jul; 35(7):1351-9. PubMed ID: 25658174
[TBL] [Abstract][Full Text] [Related]
46. Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis.
Chiang A; Chang LK; Yu F; Sarraf D
Retina; 2008 Oct; 28(9):1265-9. PubMed ID: 18628724
[TBL] [Abstract][Full Text] [Related]
47. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
48. Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment.
Vavvas DG; Daniels AB; Kapsala ZG; Goldfarb JW; Ganotakis E; Loewenstein JI; Young LH; Gragoudas ES; Eliott D; Kim IK; Tsilimbaris MK; Miller JW
EBioMedicine; 2016 Mar; 5():198-203. PubMed ID: 27077128
[TBL] [Abstract][Full Text] [Related]
49. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.
Nagiel A; Sarraf D; Sadda SR; Spaide RF; Jung JJ; Bhavsar KV; Ameri H; Querques G; Freund KB
Retina; 2015 Apr; 35(4):638-47. PubMed ID: 25650713
[TBL] [Abstract][Full Text] [Related]
50. Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.
Wolf A; Rüping J; Neubauer AS; Mayer W; Ulbig M; Haritoglou C; Holz FG; Eter N; Kampik A
Retina; 2013 Oct; 33(9):1843-9. PubMed ID: 23598795
[TBL] [Abstract][Full Text] [Related]
51. Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy.
Reibaldi M; Boscia F; Avitabile T; Russo A; Cannemi V; Uva MG; Reibaldi A
Eur J Ophthalmol; 2009; 19(1):154-8. PubMed ID: 19123167
[TBL] [Abstract][Full Text] [Related]
52. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
[TBL] [Abstract][Full Text] [Related]
53. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.
Querques G; Prascina F; Iaculli C; Noci ND
Int Ophthalmol; 2009 Apr; 29(2):103-7. PubMed ID: 18157710
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
55. Pegaptanib: choroidal neovascularization in patients with age-related macular degeneration and previous arterial thromboembolic events.
Battaglia Parodi M; Di Bartolo E; Brue C; Cappello E; Furino C; Giuffrida S; Imparato M; Reibaldi M
Eur J Ophthalmol; 2018 Jan; 28(1):58-62. PubMed ID: 29077191
[TBL] [Abstract][Full Text] [Related]
56. [Avascular retinal pigment epithelium detachments in age-related macular degeneration].
Budzinskaya MV; Plyukhova AA; Tarasenkov AO
Vestn Oftalmol; 2020; 136(4. Vyp. 2):284-288. PubMed ID: 32880152
[TBL] [Abstract][Full Text] [Related]
57. Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment.
Shijo T; Sakurada Y; Tanaka K; Miki A; Sugiyama A; Onoe H; Chubachi A; Kikushima W; Wakatsuki Y; Yoneyama S; Mori R; Kashiwagi K
Sci Rep; 2022 Mar; 12(1):4715. PubMed ID: 35304557
[TBL] [Abstract][Full Text] [Related]
58. Cystoid macular degeneration in chronic central serous chorioretinopathy.
Iida T; Yannuzzi LA; Spaide RF; Borodoker N; Carvalho CA; Negrao S
Retina; 2003 Feb; 23(1):1-7; quiz 137-8. PubMed ID: 12652224
[TBL] [Abstract][Full Text] [Related]
59. Activated Retinal Pigment Epithelium, an Optical Coherence Tomography Biomarker for Progression in Age-Related Macular Degeneration.
Curcio CA; Zanzottera EC; Ach T; Balaratnasingam C; Freund KB
Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO211-BIO226. PubMed ID: 28785769
[TBL] [Abstract][Full Text] [Related]
60. Ocular toxicity of intravitreal indocyanine green.
Cheng SN; Yang TC; Ho JD; Hwang JF; Cheng CK
J Ocul Pharmacol Ther; 2005 Feb; 21(1):85-93. PubMed ID: 15718832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
